Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE
    • Publication Information:
      Publication: 2011- : New York : Springer
      Original Publication: Northwood, Middlesex, England : Science and Technology Letters, c1994-
    • Subject Terms:
    • Abstract:
      Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer which is the deadliest type of cancer for both men and women. Previous studies already showed that cell-intrinsic loss of WASp causes B cell tolerance and WASp deficiency in T helper (T H ) cells is linked to negative effects on cytokine gene transcription necessary for T H 1 differentiation. In the current study, we investigated the molecular mechanisms involved in WASp-mediated epigenetic regulation of B cell differentiation during NSCLC. Our ChIP-qPCR data suggest the less percentage enrichment of the B cell differentiating factors (Ikaros, Pax5, PU.1, BATF) and WASp across the WAS gene in the B cells of NSCLC patients in comparison with normal healthy donors and overexpression of WASp showed the reverse effects. WASp-depleted B cells while co-culturing with respective PBMCs isolated from normal healthy donors and NSCLC patients, we observed upregulation of T H 2-, T H 17-, and Treg-specific cytokines (IL4, ILI7A, IL10) & transcription factors (GATA3, RORC, FOXP3) and downregulation of T H 1-specific cytokine (IFNγ) & transcription factor (TBX21). Our study showed that the overexpression of WASp resulted into upregulation of B cell differentiating factors, tumor suppressor protein (p53), histone methylation marker (H3K4me3) with concomitant downregulation of tumor-promoting factors (Notch 1, β-Catenin, DNAPKcs) and histone deacetylation marker (HDAC2) and increase in percentage cytotoxicity of NSCLC-specific cells (A549). Successful overexpression of WASp not only helps in epigenetic regulation of B cell differentiation but also supports tumor suppression in NSCLC. Thus, WASp can be targeted for therapeutic intervention of NSCLC.
      (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
    • References:
      Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science. 1991;254(5035):1131–8. https://doi.org/10.1126/science.1957166 . (PMID: 10.1126/science.19571661957166)
      Lu F, Zhang HT. DNA methylation and nonsmall cell lung cancer. Anat Rec Adv Integr Anat Evol Biol. 2011;294(11):1787–95. https://doi.org/10.1002/ar.21471 . (PMID: 10.1002/ar.21471)
      Cardona-Monzonís A, Ortega ÁL, Carretero J, García-Giménez JL, Mena-Mollá S. Epigenetics and precision medicine in lung cancer. In: Epigenetics in precision medicine. New York: Academic Press; 2022. p. 109–45. (PMID: 10.1016/B978-0-12-823008-4.00007-X)
      Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9): a019505. https://doi.org/10.1101/cshperspect.a019505 . (PMID: 10.1101/cshperspect.a0195055008069)
      Schmidt M, Böhm D, von Törne C, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Can Res. 2008;68(13):5405–13. https://doi.org/10.1158/0008-5472.CAN-07-5206 . (PMID: 10.1158/0008-5472.CAN-07-5206)
      Guillem EB, Sampsel JW. Antitumor-associated antigens IgGs: dual positive and negative potential effects for cancer therapy. Adv Exp Med Biol. 2006;587:341–74. https://doi.org/10.1007/978-1-4020-5133-3_26 . (PMID: 10.1007/978-1-4020-5133-3_2617163176)
      Guo FF, Cui JW. The role of tumor-infiltrating B cells in tumor immunity. J Oncol. 2019;2019:2592419. https://doi.org/10.1155/2019/2592419 . (PMID: 10.1155/2019/2592419316627506778893)
      Liu C, Bai X, Wu J, et al. N-wasp is essential for the negative regulation of B cell receptor signaling. PLoS Biol. 2013;11(11): e1001704. https://doi.org/10.1371/journal.pbio.1001704 . (PMID: 10.1371/journal.pbio.10017043818172)
      Rey-Suarez I, Wheatley BA, Koo P, et al. WASP family proteins regulate the mobility of the B cell receptor during signaling activation. Nat Commun. 2020;11(1):439. https://doi.org/10.1038/s41467-020-14335-8 . (PMID: 10.1038/s41467-020-14335-8319743576978525)
      Coronella-Wood JA, Hersh EM. Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother. 2003;52(12):715–38. https://doi.org/10.1007/s00262-003-0409-4 . (PMID: 10.1007/s00262-003-0409-412920480)
      Sadhukhan S, Sarkar K, Taylor M, Candotti F, Vyas YM. The nuclear role of WASp in gene transcription is uncoupled from its ARP2/3-dependent cytoplasmic role in actin polymerization. J Immunol. 2014;193(1):150–60. https://doi.org/10.4049/jimmunol.1302923 . (PMID: 10.4049/jimmunol.1302923)
      Pal R, Rakshit S, Shanmugam G, et al. Involvement of Xeroderma Pigmentosum Complementation Group G (XPG) in epigenetic regulation of T-Helper (T H ) cell differentiation during breast cancer. Immunobiology. 2022. https://doi.org/10.1016/j.imbio.2022.152259 . (PMID: 10.1016/j.imbio.2022.15225936037675)
      Taylor M, Sadhukhan S, Kottangada P, et al. Nuclear role of WASp in the pathogenesis of dysregulated T H 1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2(37):37ra44. https://doi.org/10.1126/scitranslmed.3000813 . (PMID: 10.1126/scitranslmed.3000813205740682943146)
      Sarkar K, Sadhukhan S, Han S, Vyas YM. Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguish X-linked thrombocytopenia from Wiskott-Aldrich syndrome. Blood. 2014;124(23):3409–19. https://doi.org/10.1182/blood-2014-07-587642 . (PMID: 10.1182/blood-2014-07-587642252537724246038)
      Sarkar K, Han S, Wen K, Ochs H, Dupré L, Seidman M, Go Y. R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2018;142(1):219–34. https://doi.org/10.1016/j.jaci.2017.11.023 . (PMID: 10.1016/j.jaci.2017.11.02329248492)
      Sarkar K, Sadhukhan S, Han S, Vyas YM. SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF- B response genes in T cells. Blood. 2015;126(14):1670–82. https://doi.org/10.1182/blood-2015-05-646182 . (PMID: 10.1182/blood-2015-05-646182262612404591791)
      Bochynska A, Lüscher-Firzlaff J, Lüscher B. Modes of interaction of KMT2 histone H3 lysine 4 methyltransferase/COMPASS complexes with chromatin. Cells. 2018;7(3):17. https://doi.org/10.3390/cells7030017 . (PMID: 10.3390/cells7030017294986795870349)
      Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27–36. https://doi.org/10.1093/carcin/bgp220 . (PMID: 10.1093/carcin/bgp22019752007)
      van Weverwijk A, de Visser KE. Mechanisms driving the immunoregulatory function of cancer cells. Nat Rev Cancer. 2023;23:193–215. https://doi.org/10.1038/s41568-022-00544-4 . (PMID: 10.1038/s41568-022-00544-436717668)
      Han SS, Wen KK, Vyas YM. Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes. Oncogene. 2021;40(2):345–54. https://doi.org/10.1038/s41388-020-01533-3 . (PMID: 10.1038/s41388-020-01533-333139832)
      Westerberg L, Larsson M, Hardy SJ, Fernández C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005;105(3):1144–52. https://doi.org/10.1182/blood-2004-03-1003 . (PMID: 10.1182/blood-2004-03-100315383456)
      Sun X, Wei Y, Lee PP, Ren B, Liu C. The role of WASp in T cells and B cells. Cell Immunol. 2019;341: 103919. https://doi.org/10.1016/j.cellimm.2019.04.007 . (PMID: 10.1016/j.cellimm.2019.04.00731047647)
      Santos PM, Borghesi L. Molecular resolution of the B cell landscape. Curr Opin Immunol. 2011;23(2):163–70. https://doi.org/10.1016/j.coi.2010.11.014 . (PMID: 10.1016/j.coi.2010.11.014212366543073704)
      Taylor MD, Sadhukhan S, Kottangada P, et al. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2(37):44. https://doi.org/10.1126/scitranslmed.3000813 . (PMID: 10.1126/scitranslmed.3000813)
      Biswas A, Shouval DS, Griffith A, et al. WASP-mediated regulation of anti-inflammatory macrophages is IL-10 dependent and is critical for intestinal homeostasis. Nat Commun. 2018;9(1):1779. https://doi.org/10.1038/s41467-018-03670-6 . (PMID: 10.1038/s41467-018-03670-65934380)
      Ferreirós-Vidal I, Carroll T, Taylor B, et al. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B–cell differentiation. Blood J Am Soc Hematol. 2013;121(10):1769–82. https://doi.org/10.1182/blood-2012-08-450114 . (PMID: 10.1182/blood-2012-08-450114)
      Holmes ML, Pridans C, Nutt SL. The regulation of the B-cell gene expression programme by Pax5. Immunol Cell Biol. 2008;86(1):47–53. https://doi.org/10.1038/sj.icb.7100134 . (PMID: 10.1038/sj.icb.7100134)
      Yang X, Wang B, Cao X. Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy. Cancer Commun. 2021;41(11):1228. https://doi.org/10.1002/cac2.12222 . (PMID: 10.1002/cac2.12222)
      Libregts SF, Gutiérrez L, de Bruin AM, et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU. 1 axis. Blood J Am Soc Hematol. 2011;118(9):2578–88. https://doi.org/10.1182/blood-2010-10-315218 . (PMID: 10.1182/blood-2010-10-315218)
      Engeland K. Cell cycle regulation: p53–p21-RB signaling. Cell Death Differ. 2022;29(5):946–60. https://doi.org/10.1038/s41418-022-00988-z . (PMID: 10.1038/s41418-022-00988-z9090780)
      Yang J, Huang Y, Song M, et al. SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway. Int J Biol Sci. 2022;18(14):5241–59. https://doi.org/10.7150/ijbs.71694 . (PMID: 10.7150/ijbs.71694361474679461674)
      Pathania R, Ramachandran S, Mariappan G, et al. Combined inhibition of DNMT and HDAC blocks the tumorigenicity of cancer stem-like cells and attenuates mammary tumor growth DNMT and HDAC inhibitors alter cancer stem cell signaling. Can Res. 2016;76(11):3224–35. https://doi.org/10.1158/0008-5472.CAN-15-2249 . (PMID: 10.1158/0008-5472.CAN-15-2249)
      Hwang HK, Kim HI, Kim SH, et al. Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3+)/activated cytotoxic T lymphocyte (granzyme CD19+B) ratio on resected left-sided pancreatic cancer. Oncol Lett. 2016;12(6):4477–84. https://doi.org/10.3892/ol.2016.5252 . (PMID: 10.3892/ol.2016.5252281051575228542)
      Chatterjee A, Rodger EJ, Eccles MR. Epigenetic drivers of tumourigenesis and cancer metastasis. In: Seminars in cancer biology, vol. 51. New York: Academic Press; 2018. p. 149–59.
      Adriani M, Aoki J, Horai R, Thornton AM, Konno A, Kirby M, Anderson SM, Siegel RM, Candotti F, Schwartzberg PL. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol (Orlando, FL). 2007;124(1):41–8. https://doi.org/10.1016/j.clim.2007.02.001 . (PMID: 10.1016/j.clim.2007.02.001)
      Zan H, Casali P. Epigenetics of peripheral B-cell differentiation and the antibody response. Front Immunol. 2015;6:631. https://doi.org/10.3389/fimmu.2015.00631 . (PMID: 10.3389/fimmu.2015.006314677338)
    • Grant Information:
      ECR/2016/000965 Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Govt. of India
    • Contributed Indexing:
      Keywords: B cell differentiating factors; B cells; Cytokines; Epigenetics; Non-small-cell lung cancer (NSCLC); T helper (TH) cells; Tumor suppressor; Wiskott-Aldrich syndrome protein (WASp)
    • Accession Number:
      0 (Cytokines)
      0 (Histones)
      0 (Transcription Factors)
      0 (Wiskott-Aldrich Syndrome Protein)
    • Publication Date:
      Date Created: 20231225 Date Completed: 20231227 Latest Revision: 20240328
    • Publication Date:
      20240329
    • Accession Number:
      10.1007/s12032-023-02264-7
    • Accession Number:
      38146020